Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...
Berenberg Bank Remains a Hold on Pfizer (PFE)
In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...
StockNews10d
3 AI-Powered Drug Discovery Stocks Revolutionizing Medicine
The pharmaceutical industry is evolving continuously with the advancements in drug discovery with Artificial Intelligence (AI ...
Pfizer: It's Time To Play Defensive
The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...
Pfizer names James List Chief Internal Medicine Officer
Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...
Pfizer (NYSE:PFE) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...
Seeking Alpha’s Steven Cress shares his top dividend stocks: CLX, PFE, D, and more
There is no better period, given the volatility in the markets today, to rotate assets into dividend stocks, said Steven ...
Long Island Business News3d
Uniondale furniture firm expands with acquisition of upstate supplier
Uniondale-based McHugh Furnishings, a provider of specialty furnishings for education, healthcare, entertainment and ...
Nasdaq6d
Guru Fundamental Report for PFE
Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...
Yahoo Finance2d
Pfizer Inc. (PFE)
NEW YORK, February 24, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer ...